Ensysce Biosciences (ENSC) Amortizatization of Intangibles (2020 - 2021)
Ensysce Biosciences (ENSC) posted quarterly Amortizatization of Intangibles of $771556.0 for Q2 2021, up 134.92% year-over-year from $328429.0 in Q2 2020, and up 342.37% quarter-over-quarter from $174413.0 in Q1 2021.
Ensysce Biosciences (ENSC) Amortizatization of Intangibles (2020 - 2021) Analysis & Trends
Ensysce Biosciences (ENSC) has reported Amortizatization of Intangibles for 2 consecutive years, with $771556.0 the latest figure, recorded in Q2 2021.
- In Q2 2021, Amortizatization of Intangibles rose 134.92% year-over-year to $771556.0; the TTM figure through Dec 2021 stood at $945969.0 (up 54.16% YoY), while the FY2021 annual figure was $945969.0, up 54.16% from the prior year.
- Amortizatization of Intangibles improved to $771556.0 in Q2 2021 per ENSC's latest filing, from $174413.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $771556.0 in Q2 2021 and bottomed at $31428.0 in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 678,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Ensysce Biosciences | 942,649.19 | -3.37 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 771,556.00 |
| Jun 30, 2021 | 771,556.00 |
| Mar 31, 2021 | 174,413.00 |
| Mar 31, 2021 | 174,413.00 |
| Dec 31, 2020 | 139,149.00 |
| Dec 31, 2020 | 139,149.00 |
| Sep 30, 2020 | 114,604.00 |
| Sep 30, 2020 | 114,604.00 |
| Jun 30, 2020 | 328,429.00 |
| Jun 30, 2020 | 328,429.00 |
| Mar 31, 2020 | 31,428.00 |
| Mar 31, 2020 | 31,428.00 |